Skip to main content
Poltreg S.A. logo

Poltreg S.A. — Investor Relations & Filings

Ticker · PTG ISIN · PLPLTRG00038 LEI · 259400XSAJTERJ42VZ86 WAR Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2024-03-12 Regulatory Filings
Country PL Poland
Listing WAR PTG

About Poltreg S.A.

https://poltreg.com/

Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.

Recent filings

Filing Released Lang Actions
Otrzymanie zgody na wytwarzanie produktu leczniczego terapii zaawansowanej - wyjątku szpitalnego w Wytwórni Farmaceutycznej PolTREG S.A. od Głównego Inspektoratu Farmaceutycznego - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (815 characters) and appears to be a formal notification regarding regulatory approval for manufacturing an advanced therapy medicinal product (ATMP) from the Chief Pharmaceutical Inspectorate (GIF). It references previous reports and announces a new regulatory milestone (obtaining consent for hospital exemption manufacturing). This type of specific, non-standard regulatory update that doesn't fit into core financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP) is best classified under the general regulatory announcement category.
2024-03-12 Polish
Projket uchwały
Governance Information Classification · 95% confidence The document is titled 'UCHWAŁA Nr 4 Nadzwyczajnego Walnego Zgromadzenia spółki pod firmą PolTREG Spółka Akcyjna z dnia 12 marca 2024 roku' (Resolution No. 4 of the Extraordinary General Meeting of PolTREG S.A. dated March 12, 2024) and specifically concerns 'zmiany wynagrodzenia członków Rady Nadzorczej' (change in remuneration of the Supervisory Board members). This content directly relates to the governance structure and compensation of the board, which falls under Governance Information (CGR) or potentially Remuneration Information (DEF 14A). However, since this is a formal resolution passed by the General Meeting regarding the structure/remuneration of the Supervisory Board, it is most accurately classified as Governance Information (CGR), which covers internal rules and board structure, or potentially AGM-R if it were the presentation material. Given that it is a formal resolution document detailing board compensation structure, CGR is a strong fit, but DEF 14A specifically targets remuneration reports. Since this is a resolution about setting the remuneration structure, and not a full DEF 14A filing, CGR (Governance Information) is the most appropriate category for a formal resolution detailing board compensation structure within the provided definitions, as it dictates internal governance rules regarding board pay. Alternatively, since it is a resolution from a General Meeting, AGM-R is also plausible, but AGM-R is defined as 'Presentations and materials shared during the Annual General Meeting (AGM)'. This is a formal resolution document, not a presentation. Therefore, CGR is the best fit for a document detailing board remuneration structure set by a resolution.
2024-03-06 Polish
Zgłoszenie przez akcjonariusza projektu uchwały na Nadzwyczajne Walne Zgromadzenie PolTREG S.A. - Content (PL)
Remuneration Information Classification · 99% confidence The document is very short (639 characters) and originates from a Polish entity (PolTREG S.A.). The text explicitly states that a shareholder (Allianz Polska Otwarty Fundusz Emerytalny) submitted a draft resolution ('projekt uchwały') concerning the remuneration of the Supervisory Board members for an upcoming Extraordinary General Meeting ('Nadzwyczajnym Walnym Zgromadzeniem Spółki'). Crucially, the last sentence states: 'Zgłoszony projekt uchwały stanowi załącznik do niniejszego raportu' (The submitted draft resolution constitutes an attachment to this report). This structure—a brief announcement stating that the actual material (the resolution draft) is attached—strongly suggests this is an announcement about the publication of related materials rather than the full report itself. Since the content relates to shareholder voting/meeting materials (specifically a resolution for an EGM), the most fitting category is AGM-R (AGM Information), as it covers materials shared for general meetings, even if it's an EGM announcement.
2024-03-06 Polish
Otrzymanie zezwolenia na wytwarzanie badanego produktu leczniczego terapii zaawansowanej dla Wytwórni Farmaceutycznej PolTREG S.A. od Głównego Inspektoratu Farmaceutycznego - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a short announcement (1224 characters) written in Polish, referencing a previous report (raport bieżący nr 23/2023). It details receiving a manufacturing/import license for a medicinal product (TREG) from the Chief Pharmaceutical Inspectorate (Główny Inspektorat Farmaceutyczny). This is a specific regulatory update concerning operational capabilities and regulatory milestones necessary for clinical trials. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific regulatory update that doesn't fit perfectly into the other specialized categories (like DIRS, DIV, CAP), and it is a formal notification, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous, material, non-financial regulatory event announcement.
2024-03-06 Polish
CV
Board/Management Information Classification · 99% confidence The document text provides a detailed curriculum vitae (CV) or professional biography for an individual, listing extensive experience serving on Supervisory Boards (Rada Nadzorcza) of various Polish public companies (SA) and detailing professional roles in investment management (TFI PZU SA, PZU Asset Management SA). This type of document, which details the background, qualifications, and experience of board members or senior executives, is typically associated with corporate governance disclosures, often required when nominating directors or providing background information on existing management/supervisory bodies. Among the provided codes, 'Board/Management Information' (MANG) is the most appropriate fit, as it covers announcements of changes or profiles of the company's board of directors or senior management. It is not a formal regulatory filing like 10-K or ER, nor is it a specific report like an Audit Report (AR) or a Dividend Notice (DIV).
2024-02-29 Polish
Zgłoszenie kandydata na Członka Rady Nadzorczej PolTREG S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document is a regulatory announcement from a Polish company (PolTREG S.A.) informing the market that a shareholder (Allianz Polska Otwarty Fundusz Emerytalny) has submitted a nomination for a new member of the Supervisory Board (Rada Nadzorcza) ahead of an Extraordinary General Meeting (Nadzyczajne Walne Zgromadzenie). The text explicitly mentions the submission of a candidate's CV as an attachment ('Życiorys zawodowy w/w kandydata stanowi załącznik do niniejszego raportu'). This content directly relates to changes in the company's board of directors or senior management nominations. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short (1105 chars), but it is reporting the substance of the management change nomination, not just announcing the publication of a separate report, making MANG a better fit than RPA or RNS.
2024-02-29 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.